Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Status:
Completed
Trial end date:
2015-12-18
Target enrollment:
Participant gender:
Summary
This is a 12-month study investigating the effectiveness and safety of tofactinib in treating
the signs and symptoms of active psoriatic arthritis and improving physical function and
preserving bone structure in patients with an inadequate response to a traditional,
nonbiologic disease-modifying antirheumatic drug. Adalimumab is used as a comparator.